| Product Name | MF | CAS | Details |
|---|
| Parecoxib Impurity 27 | C16H11Cl2NO5S2 | 1373038-63-1 | Details |
| Parecoxib Impurity 12 | C19H18N2O4S | 2229657-81-0 | Details |
| Parecoxib Impurity 23 | C20H20N2O4S | 198470-82-5 | Details |
| Parecoxib Impurity 26 | C16H13NO | 75115-00-3 | Details |
| Parecoxib Impurity 20 | C16H14N2O3S | 181696-12-8 | Details |
| Parecoxib Impurity 16 | C19H18N2O4S | 2235371-89-6 | Details |
| Palbociclib Impurity 16 | C16H16N4O4 | 16264-05-4 | Details |
| Parecoxib Impurity 13 | C22H23N3O7S2 | 1708094-99-8 | Details |
| Parecoxib Impurity 24 | C20H21N2NaO4S | 198470-83-6 | Details |
| DL-Methionine Sulfoxide | C27H35N7O3 | 571189-65-6 | Details |
| Palbociclib Impurity 18 | C29H38ClN7O4 | 1883672-48-7 | Details |
| Paliperidone Impurity 3 | C18H17ClN2O2 | 147687-17-0 | Details |
| Paliperidone Impurity 7 | C11H16N2O2 | 849903-79-3 | Details |
| Palbociclib Impurity 20 | C22H28ClN7O | 571189-66-7 | Details |
| Parecoxib Impurity 52 | C18H18N2O3S | 473465-11-1 | Details |
| Pemetrexed EP Impurity E(Disodium Salt) | C20H21N5Na2O6** | 937370-10-0 | Details |
| Parecoxib Impurity 10 | C18H16N2O4S | 198471-06-6 | Details |
| Parecoxib Impurity 6 | C16H14N2O3S | 1373038-56-2 | Details |
| Parecoxib Impurity 9 | C32H25N3O6S2 | 1373038-60-8 | Details |
| Pimavanserin Impurity1 | C14H13F2N | 646051-52-7 | Details |
| C25H22FNO3 | Details |
| Policresulen Impurity 1 | C7H11NO4S | 79093-71-3 | Details |
| Policresulen Impurity 10 | C15H17NaO8S2 | 79093-74-6 | Details |
| Policresulen Impurity 4 | C7H8O4S | 7134-05-6 | Details |
| Pralidoxime Chloride Impurity1 | C7H8ClNO2 | 3697-38-9 | Details |
| Policresulen Impurity 7 | C7H8O7S2 | 15509-33-8 | Details |
| Policresulen Impurity 5 | C7H8O4S | 132281-59-5 | Details |
| Policresulen Impurity 9 | C15H16O8S2 | 78480-14-5 | Details |
| Pralidoxime Chloride Impurity3 | C7H9N2O+ | 45750-74-1 | Details |
| Pimavanserin Impurity2 | C14H13F2N | 134227-41-1 | Details |
| Pimavanserin Impurity8 | C9H10FNO | 86010-68-6 | Details |
| Pimavanserin Impurity6 | C19H23FN2O2 | 1388858-78-3 | Details |
| Pimavanserin Impurity4 | C23H32N2O3 | 955997-87-2 | Details |
| Pantoprazole EP Impurity A | C16H15F2N3O5S | 127780-16-9 | Details |
| Pantoprazole impurity 5 | C16H15F2N3O6S | 953787-55-8 | Details |
| Palbociclib Impurity 3 | C29H37N7O4 | 1651214-74-2 | Details |
| (3R,5S,E)-methyl 7-(2-cyclopropyl | C26H26FNO4 | 849811-78-5 | Details |
| (3R,5S,E)-ethyl 7-(2-cyclopropyl | C27H28FNO4 | 167073-19-0 | Details |
| (3R,5S,E)-tert-butyl 7-(2-cyclopropyl-4- | C29H32FNO4 | 586966-54-3 | Details |
| monocalcium mono((3S,5R,E)-7-(2-cyclopropyl- | C25H26CaFNO4 | 254452-88-5 | Details |
| Pramipexole Impurity A | C7H11N3S | 106092-09-5 | Details |
| Policresulen Impurity 2 | C7H8O4S | 22356-80-5 | Details |
| Linagliptin Impurity CD10133 | C18H21N3O4S | 117976-47-3 | Details |
| (R)-Amlodipine | C25H26CaFNO4 | 254452-92-1 | Details |
| Pitavastatin IMpurity 31 | C19H16FNO | Details |
| Pramipexole Impurity E | C10H15N3OS | 106006-84-2 | Details |
| (3R,5S)-5-(6-cyclopropyl-10-fluorobenzo | C25H22FNO4 | 1187966-93-3 | Details |
| (3R,5S,6Z)-Pitavastatin Calcium | C25H26CaFNO4 | 1159588-21-2 | Details |
| Pramipexole Impurity D | C10H17N3S | 104632-28-2 | Details |
| (S,E)-ethyl 7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl) | C27H26FNO4 | 148901-69-3 | Details |
| tert-butyl 2-((4R,6S) | C32H36FNO4 | 147489-06-3 | Details |
| monocalcium mono | C25H24FNO4 | 769908-13-6 | Details |
| Pantoprazole EP Impurity D | C17H17F2N3O4S | 624742-53-6 | Details |
| Palbociclib Impurity 4 | C22H27BrClN7O | 850918-83-1 | Details |
| Pantoprazole IMpurity C | C8H6F2N2OS | 97963-62-7 | Details |
| Pantoprazole IMpurity B | C16H15F2N3O3S | 102625-64-9 | Details |
| Parecoxib sodium | C19H19N2NaO4S | 198470-85-8 | Details |
| Paroxetine Impurity 3 | C20H24FNO6S | 217797-14-3 | Details |
| Paroxetine Impurity 1 | C19H22FNO | 201855-60-9 | Details |
| Paroxetine Impurity 2 | C19H20FNO3 | 61869-08-7 | Details |
| Pantoprazole EP Impurity F | C17H17F2N3O4S | 721924-06-7 | Details |
| Pantoprazole EP Impurity | C16H15F2N3O5S | 953787-60-5 | Details |
| posaconazole impurity 19 | C21H21F2N3O4S | 159811-30-0 | Details |
| RaMelteon iMpurity A | C11H10O2 | 196597-78-1 | Details |
| Ramelteon Impurity B | C13H11NO | 196597-79-2 | Details |
| RaMelteon iMpurity D | C17H23NO2 | 880152-61-4 | Details |
| RaMelteon iMpurity E | C15H19NO2 | 196597-16-7 | Details |
| Vitamin B6 Impurity 54 | C37H42F2N8O5 | 1902954-05-5 | Details |
| N-Nitroso Furosemide | C37H42F2N8O5 | 1902954-03-3 | Details |
| posaconazole impurity 17 | C21H21F2N3O4S | 149809-42-7 | Details |
| posaconazole impurity 14 | C20H18ClF2N3O4S | 175712-02-4 | Details |
| Palbociclib Isethionate | C26H35N7O6S | 827022-33-3 | Details |
| Palbociclib Impurity 22 | C22H26BrN7O | 851067-56-6 | Details |
| Palbociclib Impurity 23 | C27H34BrN7O3 | 571188-82-4 | Details |
| Palbociclib Impurity 24 | C33H45N7O4 | 866084-31-3 | Details |
| Palbociclib Impurity 5 | C24H31N7O2 | 1376615-91-6 | Details |
| Paliperidone Impurity 10 | C23H27FN4O4 | 761460-08-6 | Details |
| Paliperidone Impurity 1 | C11H15ClN2O2 | 130049-82-0 | Details |
| Paliperidone Impurity 4 | C18H18N2O3 | 1008796-22-2 | Details |
| Paliperidone Impurity 5 | C11H12N2O3 | 181525-38-2 | Details |
| Paliperidone Impurity 2 | C11H11ClN2O2 | 260273-82-3 | Details |
| Paliperidone Impurity 6 | C11H12N2O2 | 70381-47-4 | Details |
| Paliperidone Impurity 8 | C11H14N2O2 | 1008796-23-3 | Details |
| Parecoxib Impurity 21 | C16H15NO2 | 181696-73-1 | Details |
| Pregabalin Impurity B | C9H17NO3 | 181289-33-8 | Details |
| (S)-2-((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo | C25H28N6Na3O93* | 1265908-59-5 | Details |
| Pemetrexed EP Impurity | C21H23N5O6 | Details |
| Noradrenaline Impurity 61 | C18H21N3O5S | 924663-37-6 | Details |
| 2-(((4-methoxy-3-methylpyridin-2-yl) | C15H15N3O2S | 102804-77-3 | Details |
| 2-(((4-methoxy-3-methylpyridin-2-yl)methyl)thio)- | C15H15N3OS | 102804-82-0 | Details |
| Rabeprazole Impurity 1 | C7H6N2 | 51-17-2 | Details |
| Rabeprazole Impurity 2 | C11H16ClNO2 | 117977-20-5 | Details |
| Lactate tetramer | C18H21N3O4S | 924663-38-7 | Details |
| (R)-Amlodipine | C14H11N3O3 | 1163685-30-0 | Details |
| Tofacitinib Impurity FD+DX | C18H21N3O2S | 117977-21-6 | Details |
| Parecoxib Impurity 2 | C16H12ClNO3S | 509074-26-4 | Details |
| Parecoxib Impurity 1 | C16H13NO | 37928-17-9 | Details |
| Parecoxib Impurity 7 | C16H15N3O5S2 | 1373038-59-5 | Details |
| Parecoxib Impurity 4 | C16H14N2O3S | 181695-72-7 | Details |
| Parecoxib Impurity 3 | C16H13NO4S | 181696-35-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 | ||||